Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-15

Clinical Trial Update: Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA) [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing intravenous vs oral iron for restless legs syndrome with iron deficiency anemia completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous iron
  • Oral iron (ferrous sulfate)

Snippet

Sponsor: Auerbach Hematology Oncology Associates P C | Conditions: Restless Legs Syndrome, Iron Deficiency Anemia | Phase 2 | Status: COMPLETED | Results posted: 2023-08-15